NCT02112032 2021-05-05
Treatment of Advanced Melanoma With MK-3475 and Peginterferon
University of Pittsburgh
Phase 1 Completed
Clinical Trials
5 trialsNCT00791271 2018-11-09
Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00457418 2017-06-07
High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01496807 2017-04-28
Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00861406 2017-03-03
Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine
M.D. Anderson Cancer Center
Phase 1 Completed